Soft Tissue Allografts Market Size

Soft Tissue Allografts Market Analysis

The soft tissue allografts market is expected to witness a CAGR of 6.7% during the forecast period.

COVID-19 impacted the soft tissue allografts market in its initial phase owing to the cancellations of soft tissue repair procedures. For instance, according to an article published in the International Journal of Environmental Research and Public Health in March 2021, a study was conducted in Poland which showed that the pandemic has substantially impacted the number of dental procedures performed including dental repair procedures, in the initial phase of the pandemic. Furthermore, according to an article published in Cureus Journal in September 2022, a study was conducted in Scotland that stated the total number of hernia repair surgeries taking place in the country reduced considerably during the initial pandemic. The majority of this was due to the decrease in the number of elective operations, with the percentage of elective repair surgeries reducing significantly from 85.6% to 58.4%. However, the market recovered in the last two years since the restrictions were lifted and soft tissue allograft procedures resumed worldwide. The market is expected to register a stable growth rate during the forecast period.

According to the data published by the National Safety Council of the United States in 2021, an estimated 3.2 million people were treated in emergency departments for injuries involving sports and recreational equipment in the United States in 2021. The most common activities that were frequently associated with injuries were exercise, cycling, and basketball. The injury rate for exercise was 123.8 per 100,000 population in the United States in 2021, for bicycles and accessories it was 113.7, for basketball it was 78.6, for skateboards, scooters, and hoverboards it was 74.2, and for football, it was 67.2. Therefore, the large number of sports injuries leads to rising demand for soft tissue allografts in athletics and other sports, thereby contributing largely to the market growth.

Soft tissue allografts are used in spinal surgery and osteochondral defects during knee surgery. The high burden of such cases is expected to propel market growth. For instance, an article published in Médecine Intensive Réanimation in September 2021 stated that the number of spinal cord injuries is around 2000 new cases per year in France. Additionally, according to the French Road Safety Observatory (ONISR), 2023 update, there were 53.5 thousand injury traffic accidents and 67.0 thousand injured people during the accident in mainland France in 2021. The high burden of spinal cord injury and road accidents is anticipated to boost the demand for the use of allografts in orthopedic and spinal surgery, thereby propelling the market growth during the forecast period.

Furthermore, the strategic initiatives adopted by market players such as innovation in technology, product approvals & launches, along with partnerships to expand the soft tissue allografts offerings contribute significantly to the market growth. For instance, in October 2021, AlloSource launched AlloMend Extra-Large (XL) Acellular Dermal Matrix (ADM), a dermal graft that offers desired handling characteristics enabling precision placement. Also, in January 2021, Direct Biologics LLC launched AmnioWrap placental-based sheet allografts for clinical use. AmnioWrap is a unique, tri-layer graft intended for applications in acute and chronic wounds. The rising approvals and partnerships are expected to propel the market growth during the forecast period.

Therefore, owing to the aforementioned factors such as the high burden of sports and road accident injuries and rising product launches by market players, the studied market is anticipated to witness growth over the analysis period. However, the high cost of treatment and complicated reimbursement and regulatory policies are expected to restrain the market growth.